125 related articles for article (PubMed ID: 33867297)
21. Reduced toxicity with equivalent outcomes using three-dimensional volumetric (3DV) image-based versus nonvolumetric point-based (NV) brachytherapy in a cervical cancer population.
Thomas KM; Maquilan G; Stojadinovic S; Medin P; Folkert MR; Albuquerque K
Brachytherapy; 2017; 16(5):943-948. PubMed ID: 28602708
[TBL] [Abstract][Full Text] [Related]
22. Inverse Planned High-Dose-Rate Brachytherapy for Locoregionally Advanced Cervical Cancer: 4-Year Outcomes.
Tinkle CL; Weinberg V; Chen LM; Littell R; Cunha JAM; Sethi RA; Chan JK; Hsu IC
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1093-1100. PubMed ID: 26194683
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session.
Oh D; Huh SJ; Park W; Ju SG; Nam H; Lee JE
Medicine (Baltimore); 2016 Jun; 95(25):e3895. PubMed ID: 27336876
[TBL] [Abstract][Full Text] [Related]
24. Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis.
Sapienza LG; Jhingran A; Kollmeier MA; Lin LL; Calsavara VF; Gomes MJL; Baiocchi G
Gynecol Oncol; 2018 Dec; 151(3):573-578. PubMed ID: 30333082
[TBL] [Abstract][Full Text] [Related]
25. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.
Wang C; Raince J; Swamy U; Park SJ; Zaide L; Mesko S; Demanes DJ; Kamrava M
Brachytherapy; 2018; 17(2):392-398. PubMed ID: 29128230
[TBL] [Abstract][Full Text] [Related]
27. Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer.
Boyrie S; Charra-Brunaud C; Harter V; Ducassou A; Kirova Y; Barillot I; Krzisch C; Lang P; Baron MH; Montbarbon X; Delannes M; Peiffert D
Brachytherapy; 2014; 13(4):326-31. PubMed ID: 24946972
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical outcomes achieved with image-guided adaptive brachytherapy for cervix cancer using CT or transabdominal ultrasound.
Tharavichitkul E; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Nobnop W; Tippanya D; Galalae RM; Chitapanarux I
Brachytherapy; 2021; 20(3):543-549. PubMed ID: 33551272
[TBL] [Abstract][Full Text] [Related]
29. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Brachytherapy; 2015; 14(1):29-36. PubMed ID: 25443528
[TBL] [Abstract][Full Text] [Related]
31. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
32. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
[TBL] [Abstract][Full Text] [Related]
33. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
[TBL] [Abstract][Full Text] [Related]
34. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
[TBL] [Abstract][Full Text] [Related]
35. Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience.
Tharavichitkul E; Chakrabandhu S; Wanwilairat S; Tippanya D; Nobnop W; Pukanhaphan N; Galalae RM; Chitapanarux I
Gynecol Oncol; 2013 Jul; 130(1):81-5. PubMed ID: 23603369
[TBL] [Abstract][Full Text] [Related]
36. 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control.
Kang HC; Shin KH; Park SY; Kim JY
Radiother Oncol; 2010 Dec; 97(3):507-13. PubMed ID: 21074881
[TBL] [Abstract][Full Text] [Related]
37. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
[TBL] [Abstract][Full Text] [Related]
38. Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
Vojtíšek R; Sukovská E; Baxa J; Budíková M; Kovářová P; Fínek J
Strahlenther Onkol; 2019 Nov; 195(11):972-981. PubMed ID: 31309266
[TBL] [Abstract][Full Text] [Related]
39. Impact of CT-based brachytherapy in elderly patients with cervical cancer.
Kobayashi D; Okonogi N; Wakatsuki M; Miyasaka Y; Kiyohara H; Ohno T; Kato S; Nakano T; Kamada T
Brachytherapy; 2019; 18(6):771-779. PubMed ID: 31506225
[TBL] [Abstract][Full Text] [Related]
40. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters.
Chargari C; Mazeron R; Escande A; Maroun P; Dumas I; Martinetti F; Tafo-Guemnie A; Deutsch E; Morice P; Haie-Meder C
Brachytherapy; 2016; 15(4):456-462. PubMed ID: 27180129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]